A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated

NCT05469646 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1819479
DRUG: Matching placebo

Sponsor

Boehringer Ingelheim